SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-13-000022
Filing Date
2013-01-25
Accepted
2013-01-25 17:01:22
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 GENESIS BIOPHARMA FORM 10-Q gnbp10q093012.htm 10-Q 708245
2 EXHIBIT 31.1 ex311.htm EX-31.1 15743
3 EXHIBIT 31.2 ex312.htm EX-31.2 15740
4 EXHIBIT 32.1 ex321.htm EX-32.1 6937
5 EXHIBIT 32.2 ex322.htm EX-32.2 6917
  Complete submission text file 0001513160-13-000022.txt   2802683

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gnpb-20120930.xml EX-101.INS 293429
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gnpb-20120930.xsd EX-101.SCH 28194
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpb-20120930_cal.xml EX-101.CAL 35591
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gnpb-20120930_def.xml EX-101.DEF 66304
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gnpb-20120930_lab.xml EX-101.LAB 191243
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gnpb-20120930_pre.xml EX-101.PRE 136610
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53127 | Film No.: 13549363
SIC: 4731 Arrangement of Transportation of Freight & Cargo